Home > Naloxone for opioid‐exposed newborn infants.

Moe-Byrne, Thirimon and Brown, Jennifer Valeska Elli and McGuire, William [The Cochrane Library] . (2018) Naloxone for opioid‐exposed newborn infants. London: John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (10) Art. No.: CD003483. DOI: 10.1002/14651858.CD003483.pub3

URL: https://www.cochranelibrary.com/cdsr/doi/10.1002/1...

Review question: Does naloxone (a drug that counters the negative effects of opioids on breathing) help newborn babies whose mothers have received opioid pain relief during birth?

Key results: The trials reported the effects of naloxone on the baby's breathing but did not assess the effect on the need for babies to be cared for in a neonatal unit (separated from their mother), whether they needed help with breathing, or on breastfeeding success. None of the trials assessed long‐term development. We did not find any trials including babies born to mothers who had used opioids (whether prescribed or non‐prescribed) during pregnancy.

Item Type:Evidence resource
Publication Type:Review
Drug Type:Opioid
Intervention Type:AOD disorder, AOD disorder drug therapy, AOD disorder treatment method, AOD disorder harm reduction
Source:The Cochrane Library
Date:October 2018
Publisher:John Wiley & Sons, Ltd
Place of Publication:London
Subjects:B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Opioid product > Naloxone
E Concepts in biomedical areas > Pregnancy
J Health care, prevention and rehabilitation > Patient care management
T Demographic characteristics > Pregnant woman
T Demographic characteristics > Child of person who uses substances

Repository Staff Only: item control page